
harmful for the infections treatment thereby leading to a greater resistance selection (Laxminarayan et al., 2016). Consequently, antibiotics become ineffective increasing the risk of disease spread, severe illness and death (Palacios-Baena et al., 2021). New strategies should be taken into account in the therapeutic approach through enhancing host immunity mechanisms or relying on new compounds, such as essential oils (Oliva et al., 2018), N-acetylcysteine (Oliva et al., 2021), bacteriophages (Qin et al., 2021), vaccines (Diago-Navarro et al., 2017) or the combination therapy (Mascellino et al., 2021) (Figure 1).The presence of enzymes, such as Extended-Spectrum β-lactamase (ESBL) and carbapenemases (KPCs, Metallo β-lactamases, OXA, GES ), constitutes the principal resistance mechanism to antibiotics. (Scudeller et al., 2021).A new metallo βlactamase , called SZM-1, is identified and characterized in Shenzhen Bay, South China by Lingxu Fang (https://www.frontiersin.org/articles/10.3389/fmicb.2022.996834/full). This Shenzhen metallo-β-lactamase belonging to an Arenimonas metagenome-assembled genome recovered from the river sediment in the Shenzhen Bay area, shows carbapenemase activity, and confers an increasing resistance towards carbapenems in the carrier bacteria.In order to test the most common resistance genes (blaKPC, blaNDM- In the first one, it is noticed that the extended-spectrum β-lactamase-producing Enterobacteriaceae colonization does not interfere with either following infections by ESBL Gram-negative bacteria or with liver transplant outcomes. Consequently, this colonization cannot be considered a risk factor for possible post-transplant Gram-negative infections even if some previous literature data provide conflicting results mainly for Gram-positive bacteria (Russel et al., 2008) In the second article, the outbreak of carbapenem-resistant Enterobacteriaceae in a thoracic-oncology unit is taken into consideration. The study includes Citrobacter freundii and E. hormaechei (both belonging to Enterobacter cloacae complex) producing OXA-48 carbapenemase in hospitalized patients.The blaOXA-48 gene is disseminated by both clonal and plasmid spread. The origin of this outbreak appears to be both external and internal to the ward deducing that this cross-infection must be managed with the implementation of approppriate prevention and control measures.Lastly, an effective new strategy for fithing the antimicrobial resisrance (AMR) could rely on increasing host immunity by making people less receptive to infections and more ready to combat them. This In conclusion, the AMR is currently a crucial issue in the management of the infectious diseases worldwide. (Jamal et al., 2020). New antibiotics, antimicrobial associations, combinations between betalactams and beta-lactamases inhibitors are taken into account even if the bacterial resistance and the therapy failures are always lurking (Bhatnagar et al., 2021). Appropriate prevention and control measures should be greatly improved (van Seventer and Hochberg, 2017). This issue constitutes an increasing problem that requires drastic solutions for limiting the further spread of resistant bacteria. Alternative therapeutic programs could be proposed, such as using N-acetyl-cisteyne, bacteriophages and more importantly vaccines stimulating the immune response that can recognize different bacterial antigenic epitopes to promote pathogen elimination.
